Survey of the Effect of Omega-3 in the Prevention of Preeclampsia”

Not Applicable

Recruiting

• Conditions: Preeclampsia in Pregnant Women Suffering Hyperlipidemia.

• Registration Number: IRCT20210426051094N1
• Lead Sponsor: Kurdistan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

Pregnant Women Suffering Hyperlipidemia that triglyceride levels is above 150 Milligrams per Deciliter.

Exclusion Criteria

Pregnant women that are suffering metabolic diseases.
Pregnant women that have the age of less than 20 years and over the age of 40 years.
Pregnant women that have a history of preeclampsia in a previous pregnancy or in a first-degree relative.
Pregnant women that have a history of having twins.
Pregnant women that have a body mass index equal to or greater than 29.
Pregnant women that have kidney disease, high blood pressure, diabetes and hyperthyroidism.
Pregnant women that use of aspirin, calcium, anticoagulants and insulin.
Pregnant women that do not have history of omega-3 allergies.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Preeclampsia. Timepoint: Before the intervention in the first month of pregnancy and 9 months after the intervention in the last month of pregnancy. Method of measurement: Blood pressure above 140 to 90 mm Hg, swelling of the hands and face, overweight, based on the results of clinical trials of the patient's blood, including protein in the urine, increased liver enzymes, decreased platelet count, increased creatine and ultrasound.